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The lysyl-tRNA synthetase paralog PoxA modifies elongation factor P (EF-P) with α-lysine at low
efficiency. Cell-free extracts contained non-α-lysine substrates of PoxA that modified EF-P by a
change in mass consistent with β–lysine, a substrate also predicted by genomic analyses. EF-P was
efficiently, functionally, modified with (R)-β-lysine but not (S)-β-lysine or genetically encoded αamino acids, indicating that PoxA has evolved an activity orthogonal to that of the canonical
aminoacyl-tRNA synthetases.
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The aminoacyl-tRNA synthetases family (aaRSs) encompasses 20 canonical enzymes that
match amino acids with their corresponding tRNAs during translation1. The aaRSs are
divided between classes I and II, each of which is characterized by a core catalytic domain
responsible for ATP-dependent acyl-adenylate synthesis2. These core domains recognize
and activate specific amino acids, which are transferred to the 3' end of tRNA. AaRSs are
highly modular and contain domains appended to the catalytic core that assist in RNA
binding and recognition, and in proofreading of incorrect aminoacylation products3. In
addition to the canonical enzymes required for translation, the aaRS superfamily contains
paralogs that recapitulate either the core or the appended domains of aaRSs4. AaRS paralogs
generally retain some degree of specificity for canonical protein synthesis substrates, amino
acid or tRNA, whether or not they function inside or outside translation5. One notable
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exception is PoxA, a paralog of lysyl-tRNA synthetase (LysRS), which does not recognize
tRNA but instead post-translationally modifies elongation factor P (EF-P), a protein that
mimics tRNA in both shape and size6–8. EF-P modification leads to specific alterations in
the proteome and is required for virulence in Salmonella, but exactly how PoxA modifies
EF-P to elicit these changes is unknown7.
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Structural studies suggest PoxA recognizes EF-P in a similar manner to that by which
LysRS binds tRNALys 7,8. Aminoacylation assays show the KM of PoxA for EF-P (3.2 µM)
is similar to values determined for bacterial class II-type LysRS with tRNALys (1–2 µM9,10).
PoxA cannot aminoacylate tRNALys, indicating that while it is structurally similar to LysRS
its activity is different from that of a canonical aaRS11. The amino acid binding pockets of
PoxA and LysRS also appear highly similar and super positioning of the α-carbons within
the active sites shows an RMSD of 1.1 Å (Fig. 1a). Using the LysRS co-crystal structure,
lysyl-adenylate can be docked into the active site of PoxA, consistent with previous findings
that lysine is a substrate for EF-P modification in vitro7. While lysine was a substrate for
PoxA, the reaction was extremely inefficient compared to amino acid activation by LysRS
(Supplementary Methods, Table 1). Characterization of amino acid activation by PoxA
under a variety of conditions did not lead to significant improvements in the efficiency of
the reaction (Supplementary Results, Supplementary Fig. 1), suggesting that lysine may not
be the cognate substrate. This was supported by comparing the PoxA and LysRS active
sites, which indicated divergence of two conserved residues predicted to impact substrate
specificity, Ser76 and Ala294 (Fig. 1a; Escherichia coli PoxA numbering). The effect of
reverting these PoxA residues to their conserved LysRS identities was investigated by
comparing the apparent amino acid binding affinities of the S76A and A294G variants to
wild-type. The S76A mutation abolished all activity, while A294G showed a 25-fold
decrease in the KM for lysine compared to wild-type (Table 1). These data indicate PoxA is
not optimized to use lysine as its preferred substrate, but has instead evolved amino acid
specificity divergent from that of LysRS.

Author Manuscript

Previous studies show different LysRSs preferentially recognize particular non-cognate
amino acids12, and the specificity of PoxA was similarly tested (Fig. 1b). PoxA did not
activate either other non-cognate genetically encoded amino acids or various commercially
available analogs more efficiently than lysine. This raised the possibility that another amino
acid was the preferred substrate of PoxA in vivo. E. coli cell-free extracts showed
significantly higher stimulation of ATP / PPi exchange activity than expected based solely
upon their lysine content, suggesting the presence of a second, more efficient, substrate
(Supplementary Fig. 2a). Cell-free extracts were fractionated and the resulting samples
tested for ATP / PPi exchange activity using LysRS and PoxA (Supplementary Fig. 2b).
Optimal activities for LysRS and PoxA did not co-fractionate during purification, supporting
the idea that E. coli cell-free extracts contained a substrate for EF-P modification distinct
from lysine (Fig. 1c). The identity of the amino acid attached by PoxA in vivo was
investigated by mass spectroscopy of both affinity purified EF-P, and of EF-P modified in
vitro using enriched cell-free extracts. In both cases EF-P was site-specifically modified at
Lys34 by a mass consistent with the attachment of lysine (Supplementary Fig. 3). These data
showed that while the genetically encoded amino acid α-lysine was not the optimal substrate
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for PoxA, EF-P is nevertheless modified by a compound with the mass of lysine, consistent
with previous reports8,13.
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Genomic and phylogenetic studies predict that β-lysine might be the natural substrate for
PoxA6,7, consistent with the mass observed for modified EF-P and with the detection in vivo
of a substrate distinct from α-lysine. (R)-β-lysine was 100-fold more efficient as a substrate
than either (S)-β-lysine or α-lysine (Fig. 2a), suggesting that (R)-β-lysine is the cognate
substrate for EF-P modification (Table 1). In contrast, (R)-β-lysine was a poor substrate
compared to α-lysine for LysRS (Supplementary Fig. 4a) indicating that the amino acid
substrate specificity of PoxA is different to that of the ancestral aaRS from which it evolved.
The ability of PoxA to post-translationally modify EF-P with β-lysine was examined in vitro
and found to be considerably more efficient than modification with α-lysine (Fig. 2b). βlysine was also a potent inhibitor of α-lysine modification of EF-P, consistent with this
reaction being orthogonal to tRNA aminoacylation by LysRS (Supplementary Fig. 4b).

Author Manuscript

Previous studies established that EF-P, PoxA and the 2,3-β-lysine aminomutase encoded by
yjeK8,14 act together in vivo to establish virulence in Salmonella, and are important for
maintenance of stress resistance phenotypes including resistance to gentamicin and growth
on AB2 media7,15. The latter phenotype was used to assess how modification with β-lysine
affects the functional activity of EF-P in vivo. Complementation of a poxA yjeK double
knockout strain showed that neither wild-type PoxA nor the A298G variant could restore
normal growth on AB2 media, suggesting that lysylation alone (as opposed to β-lysylation)
is not sufficient to create functional EF-P (Supplementary Fig. 5). To more directly
investigate the role of β-lysylation of EF-P in vivo, we attempted to restore the growth of the
yjeK mutant on gentamicin by supplementation with different forms of lysine. β-lysine, but
not α-lysine, was able to restore growth of the yjeK mutant in the presence of gentamicin
(Fig. 2c). These data show that functional EF-P is dependent on post-translational
modification by PoxA specifically with β-lysine, and that synthesis of β-lysine by YjeK
occurs prior to addition rather than by a post-addition rearrangement of α-lysine.
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Perturbation of the post-translational modification of EF-P by PoxA gives rise to changes in
translation that attenuate Salmonella virulence7,15,16. The chemical nature of this novel
modification is a critical determinant of EF-P activity; while both α- and β-lysine are
substrates for PoxA, only the latter amino acid generates the biologically active form of EFP. What remains unclear is how attachment of β-lysine changes the activity of EF-P. One
possibility is that β-lysine acts as a recognition element for ribosome binding, although this
may not be a universal role as unmodified isoforms of EF-P can also bind to bacterial
ribosomes17 and a number of bacteria encode EF-P but not PoxA or YjeK6. Comparisons to
the eukaryotic homolog eIF5a18 suggest that addition of β-lysine may contribute to the
ability of EF-P to promote translation initiation and /or elongation13,19. The modification of
eIF5a with hypusine, by an unrelated pathway, is required for its stimulatory effect on
translation20, and the availability of a defined in vitro modification system will now allow
similar effects to be tested for with EF-P. The availability of a defined modification system
in vivo will in addition facilitate investigation of the proposal that EF-P stimulates
translation of specific messages7,16, a role also proposed for eIF5a but for which there is no
known mechanism18.
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Post-translational modification of EF-P is based on molecular mimicry of a pathway
hijacked from the translation machinery. To achieve the substrate specificity necessary to
modify EF-P with β-lysine, PoxA evolved two specificities orthogonal to those of the
protein from which it is derived, the class II-type LysRS. Elimination of the amino-terminal
anticodon-binding domain of LysRS would have substantially reduced affinity for tRNA10,
and allowed PoxA to evolve the protein-protein interactions that permit it to specifically
recognize the tRNA-mimic EF-P8 but not tRNALys. The evolution of amino acid specificity
in PoxA appears to have been primarily driven by selection for β-lysine as a substrate, and
may have been facilitated by the lack of selection to maintain a high turnover rate. The
biological role of LysRS, providing Lys-tRNALys for protein synthesis, requires a high rate
of product synthesis whereas PoxA would be required to have a far lower turnover rate. As a
result, only very few active site replacements compared to LysRS are sufficient to provide
PoxA with useful β-lysine specificity, since any accompanying loss in turnover number is
still compatible with a biologically relevant rate of EF-P modification.
Many aaRS paralogs have been sequenced and annotated, but to date functions have only
been assigned to a small fraction4,21,22. The relative ease with which PoxA apparently
acquired new substrate specificities suggests that alternative mechanisms of posttranslational modification, and amino acid-dependent transformations, may be associated
with other aaRS paralogs. The substrate specificity of PoxA also opens up the possibility
that aaRS paralogs could provide the basis for new tools for protein design and engineering.
The orthogonality of PoxA to the translation machinery mirrors that of systems developed
for co-translational insertion of unnatural amino acids23, suggesting that similar approaches
could be developed in the future to evolve new post-translational protein modification
activities.
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Figure 1. Amino acid recognition by PoxA

(a) The 20 amino acids forming the lysyl-adenylate binding pocket of PoxA and LysRS are
identical, apart from the two positions indicated in red. For clarity, only 14 residues are
represented. Crystal structures are LysRS from Bacillus stearothermophilus24 and PoxA
from Salmonella enterica Typhimurium7. The Van der Waals surface of the lysyl-adenylate
is represented. S. enterica Ala298 corresponds to E. coli Ala294. (b) PoxA-catalyzed
ATP/PPi exchange in the presence of non-cognate amino acids (single letter code) and
lysine analogs. The concentration of each amino acid was 20 mM. Errors correspond to the
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standard deviation from three independent experiments. (c) Metabolite fractionation by LC
on silica gel. Fractions were separately tested for stimulation of ATP/PPi exchange
catalyzed by PoxA (○) or LysRS (□).
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Figure 2. Modification of EF-P with β-lysine

(a) Lysine structures (b) PoxA catalyzed aminoacylation of EF-P with (R)-β-lysine.
Aminoacylation of EF-P or the inactive K34A variant was assayed in the presence or
absence of 20µM (R)-β-lysine, (S)-β-lysine, or α-lysine. Modified EF-P containing an
additional –NH3+ group was separated from the unmodified EF-P by 1D isoelectric focusing
and detected by western blotting. (c) Complementation of Salmonella ΔyjeK strain with (R)β-lysine. Growth in liquid LB with (+) or without (−) 8 µg/ml gentamicin for 24 hours at 37
°C. Growth was monitored in the presence of either 0.8 mM (R)-β-lysine, 0.8 mM α-lysine,
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or no lysine (−). Optical densities of replicate cultures are plotted. Growth rates were
consistently slower on β-lysine than on α-lysine, suggesting a modest inhibitory effect at the
concentrations used, the reason for which is presently unclear.
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Steady-state kinetics of amino acid activation by E. coli LysRS and PoxA.
kcat (min−1)

kcat / KM (min−1µM−1)

43

3000

70

8600 ± 1200

15 ± 1.3

17 × 10−4

344 ± 44

3.8 ± 0.6

111 × 10−4

KM (µM)
L-α-lysine
LysRS1
PoxA
PoxA A294G

(R)-β-lysine
PoxA

213 ± 31

36 ± 3.3

1690 ×10 −4

PoxA A294G

414 ± 63

17 ± 0.5

410 × 10−4

2.8 ± 0

4 × 10−4

(S)-β-lysine
PoxA

6950 ± 1894
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1

Values previously determined for the lysS-encoded protein25. Errors correspond to the standard deviation from three independent experiments.
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